You can buy or sell Electromed and other stocks, options, ETFs, and crypto commission-free!
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. It offers smartvest, and airways clearance system to patients with compromised pulmonary function. Read More It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.
New Prague, Minnesota
52 Week High
52 Week Low
Advertising and Marketing
Simply Wall StMar 11
Electromed, Inc.’s (NYSEMKT:ELMD) Earnings Dropped -7.7%, How Did It Fare Against The Industry?
Analyzing Electromed, Inc.’s (NYSEMKT:ELMD) track record of past performance is a valuable exercise for investors. It enables us to reflect on whether or not the company has met expectations, which is a powerful signal for future performance. Today I will assess ELMD’s recent performance announced on 31 December 2018 and compare these figures to its long-term trend and industry movements. Check out our latest analysis for Electromed Despite a decline, did ELMD underperform the long-term trend and the indu...
Simply Wall StFeb 13
Is Electromed, Inc.’s (NYSEMKT:ELMD) ROE Of 8.6% Impressive?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. We’ll use ROE to examine Electromed, Inc. (NYSEMKT:ELMD), by way of a worked example. Over the last twelve months Electromed has recorded a ROE of 8.6%. One way to conceptualize this, is...
Electromed, Inc. Announces Fiscal 2019 Second Quarter Financial Results
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2018 (Q2 FY 2019). Q2 FY 2019 Highlights Net revenue increased 15.1% to $8.0 million from $7.0 million during the three months ended December 31, 2017 (Q2 FY 2018). Gross profit rose 12.2% to $6.1 million from $5.4 million in Q2 FY 2018. Operating income declined to $672,000, from $771,000 in Q2 FY 2018...
Expected May 7, After Hours